Effect of Oxysterol-Induced Apoptosis of Vascular Smooth Muscle Cells on Experimental Hypercholesterolemia by Perales, Sonia et al.
Hindawi Publishing Corporation
Journal of Biomedicine and Biotechnology
Volume 2009, Article ID 456208, 8 pages
doi:10.1155/2009/456208
Research Article
Effectof Oxysterol-InducedApoptosis of Vascular Smooth Muscle
Cells on Experimental Hypercholesterolemia
So niaP e ral e s,M .J o s´ e Alejandre,Rogelio Palomino-Morales, CarolinaTorres,
Jose Iglesias,andAnaLinares
Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada,
Campus Universitario de Fuentenueva, Avenida Severo Ochoa, s/n, 18071 Granada, Spain
Correspondence should be addressed to Ana Linares, analinar@ugr.es
Received 12 February 2009; Revised 24 May 2009; Accepted 7 July 2009
Recommended by Seamus J. Martin
Smooth muscle cells (SMCs) undergo changes related to proliferation and apoptosis in the physiological remodeling of vessels
and in diseases such as atherosclerosis and restenosis. Recent studies also have demonstrated the vascular cell proliferation and
programmed cell death contribute to changes in vascular architecture in normal development and in disease. The present study
was designed to investigate the apoptotic pathways induced by 25-hydroxycholesterol in SMCs cultures, using an in vivo/in vitro
cell model in which SMCs were isolated and culture from chicken exposed to an atherogenic cholesterol-rich diet (SMC-Ch)
and/or an antiatherogenic ﬁsh oil-rich diet (SMC-Ch-FO). Cells were exposed in vitro to 25-hydroxycholesterol to study levels of
apoptosis and apoptotic proteins Bcl-2, Bcl-XL and Bax and the expression of bcl-2 and bcl-xL, genes. The quantitative real-time
reverse transcriptase-polymerase chain reaction and the Immunoblotting western blot analysis showed that 25-hydroxycholesterol
producesapoptosisinSMCs,mediatedbyahighincreaseinBaxproteinandBaxgeneexpression.Thesechangesweremoremarked
in SMC-Ch than in SMC-Ch-FO, indicating that dietary cholesterol produces changes in SMCs that make them more susceptible
to25-hydroxycholesterol-mediated apoptosis.Ourresultssuggestthatthereplacement ofacholesterol-richdiet withaﬁshoil-rich
diet produces some reversal of cholesterol-induced changes in the apoptotic pathways induced by 25-hydroxycholesterol in SMCs
cultures, making SMCs more resistant to apoptosis.
Copyright © 2009 Sonia Perales et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
The dediﬀerentiation and proliferation/apoptosis of smooth
muscle cells (SMCs) in the arterial intima represent one
of the changes found in early atherosclerotic lesions, when
the disease is still reversible [1–3]. Cultured SMCs from
an atherosclerotic plaque showed a greater susceptibility
to apoptosis that did not vary with subculture [4]. This
ﬁnding suggests that stable and cell-intrinsic changes in
the expression of proapoptotic or antiapoptotic genes exert
a greater control over apoptosis in SMCs than do cell-
cell interactions or the microenvironment in the plaque,
indicating that this susceptibility develops in initial stages of
the disease.
The decision phase of apoptosis entails the expression of
speciﬁc pro- and antiapoptotic genes. If the sum of signals
gives apoptosis as a result, the whole protein machinery
for destruction is unleashed. The Bcl-2 protein family also
regulates the apoptosis pathways to inﬂuence cell survival;
this family forms heterodimers between apoptosis-inhibiting
proteinssuchasBcl-2,Bcl-XL,andA1,andinducingproteins
such as Bax, Bad, Bid, regulating cell survival [5]. The ratio
of anti- to proapoptotic proteins determines susceptibility to
apoptosis, especially the Bcl-2/Bax ratio [6]. SMCs express
low levels of Bcl-2 in vitro and in vivo [4, 7]. Although
SMCs in an atherosclerotic process show no major changes
in bcl-2 expression, the balance between antiapoptotic and
proapoptotic proteins can change in favor of the latter and
trigger apoptosis, mainly mediated by Bax [8, 9].
Cholesterol and its oxides are involved in the ini-
tiation of atherosclerosis [10–12]. The most numerous
cholesterol oxides found in human atheromatous plaque
are 7-hydroxycholesterol and 7-ketocholesterol, while 7-
ketocholesterol, and 25-hydroxycholesterol are the most2 Journal of Biomedicine and Biotechnology
abundant in the aortic wall of experimental animals after
a cholesterol-rich diet and are the most eﬀective to induce
cell death, especially 25-hydroxycholesterol [13]. Dietary
cholesterol is a risk factor for the development of these
atherosclerotic changes [3]. Thus, chickens have been
reported to readily develop hypercholesterolemia with a
cholesterol-rich diet, producing atherosclerotic lesions in
some cases [14–16]. Preliminary studies demonstrated that
a 20-day diet enriched with 5% cholesterol is suﬃcient to
cause hypercholesterolemia and gives rise to lipid deposits in
the main arteries that are similar to the fatty streaks observed
in the ﬁrst stages of atherosclerosis [17].
Because the presence of apoptosis in atherosclerotic
lesions can have a major impact on the progression of the
disease, characterization of oxysteroid-induced cell death is
important to understand the development of atherosclerosis,
since it is not clear how cholesterol and its oxides induce
apoptosis in SMCs. Therefore, the objective of this study
was to investigate the apoptotic pathways induced by oxys-
terols, using a cell model in which SMCs were exposed to
atherogenic factors (cholesterol-rich diet) or antiatherogenic
factors (ﬁsh oil-rich diet) [18]. These cells were then exposed
invitroto25-hydroxycholesterol,studyinglevelsofapoptosis
and apoptotic proteins Bcl-2, Bcl-XL, and Bax and the
expression of genes that encode the proteins involved in
apoptosis, bcl-2, bcl-xL.
2.Methods and Materials
2.1. Animals. The protocol of this study was approved by
the Animal Laboratory Service of the University of Granada
(Spain) and chickens received humane treatment according
to the regulations for Animal Research of the European
Union. Newborn White Leghorn male chicks (Gallus domes-
ticus), supplied by the Animal Laboratory Service of the
University of Granada, were kept in a chamber with a light
cycle from 09.00 to 21.00 hours and controlled temperature
of 29–31◦C and allowed free access to food and water.
2.2.DietandTreatment. Thedietwasstartedathatchingand
kept on until the chicks were killed (20 days after). Water
was available at all time. None of the chicks died a natural
death during the treatment nor developed any illness. Three
groups of chicks twenty days old were used, the control diet
group (C-group) was kept on a standard diet (Sanders A-
00) while treated group (Ch-group) was fed on the same
dietsupplementedwith5%w/wpowderedcholesterolmixed
homogeneously (Panreac reagent Barcelona, pure grade).
The third group (Ch-FO-group) was fed for 10 days with
a diet of 5% cholesterol and then cholesterol diet was
withdrawn and the standard diet was supplemented with
10% of ﬁsh (menhaden) oil for 10 days more. Experimental
diet was prepared daily to minimize the oxidation deteriora-
tion. Standard diet free of cholesterol contained (w/w) 42%
carbohydrate (mainly starch), 3.5% fat, and 20.5% protein.
Experimental diets were obtained by supplementation to
de standard diet with 5% of cholesterol (Ch diet) and
10% ﬁsh (menhaden) oil (FO diet). Fatty acid composition
Table 1: Fatty acid composition of control and experimental diet.
Fatty acid Control + 10% ﬁsh oil
14 0.8 6.6
16 22.3 22.3
18 8.6 5.8
Total sat. 31.7 34.8
16 : 1 n-7 3.3 9.2
18 : 1 n-9 32.4 19.5
20 : 1 n-9 0.0 0.4
Total MUFA 35.7 29.1
18 : 2 n-6 24.6 10.7
20 : 2 n-6 2.5 2.4
20 : 3 n-6 1.1 0.6
20 : 4 n-6 1.6 1.4
Total n-6 29.8 15.1
18 : 3 n-3 0.8 0.6
20 : 5 n-3 0.0 12.0
22 : 5 n-3 1.7 1.6
22 : 6 n-3 0.0 6.8
Total n-3 2.5 21.0
Total PUFA 32.3 36.1
Total unsat. 68.0 65.2
Sat./unsat. 0.47 0.53
Sat./PUFA 0.98 0.96
20 : 5/22 : 6 0.00 1.76
n-3/n-6 0.08 1.39
Results (% of fatty acid) are expressed as means of 3 determinations
of analysed diets is given in Table 1 [19]. No signiﬁcant
diﬀerences were observed in fatty acid composition of each
diet during the experiments. After each treatment, animals
were decapitated and the aortic arch was removed. Animals
didnotsuﬀeratallatanystageoftheexperimentbecauseour
laboratory usually uses the anesthetic ketamine (60mg/kg of
body weight) and sodium pentobarbital (50mg/kg of body
weight) according to the regulations of the Animal Research
of the European Union. The work has a positive inform from
the Ethics Committee of the Granada University. Animals
received therapy and euthanasia methods. The research staﬀ
had the preparation and the Certiﬁcation to do experimental
work with animals. All the stages of the experiment are
adapted to the established protocol.
2.3. Smooth Muscle Cell Culture. SMCs were isolated from
the aortic arch of the chicks as described elsewhere [17]
with slight modiﬁcations and cultured in Dulbecco’s Mod-
iﬁcation of Eagle’s Medium (DMEM) supplemented with D-
glucose (4.5g/L), L-glutamate (0.584g/mL), antibiotic cock-
tail composed of penicillin (100μg/mL) and amphotericin
(0.25μg/mL) (Sigma-Aldrich, Inc.), as well as 10% (v/v) fetal
bovine serum (FBS). Medium was buﬀered with bicarbonate
and cultures were kept at 37◦C in humidiﬁed atmosphere of
95% air and 5% CO2. Medium was renewed three times a
week. Secondary cultures were initiated after either low orJournal of Biomedicine and Biotechnology 3
high passages using 0.05%/0.02% Trypsin-EDTA solution.
All experiments were conducted using 3 or 5 passages. Cells
were determined to be vascular SMCs by their hill-and-
valley conﬁguration at conﬂuence and positive ﬂuorescence
staining for smooth muscle actin and myosin [17].
2.4. 25-Hydroxycholesterol Treatment and Cytotoxicity Assay.
Cytotoxicity was analyzed by using the MTT assay
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium, bro-
mide. Sigma). SMCs were plated in 96-well plates at a
density of 25000cells/well. After adhering during overnight
culture, cells were treated for 24 and 48 hours with
25-hydroxycholesterol (5–40μg/mL) dissolved in absolute
ethanol. The ﬁnal concentration of ethanol in the culture
medium never exceeded 0.8% and no eﬀect on culture was
observed at or below this concentration.
MTT was dissolved in DMEM at a concentration of
5mg/mL. An amount of this solution equal to 10% of the
culture medium volume was added to cell cultures. After
2 hours, cultures were removed from the incubator and
washed with PBS. The formazan crystals were solubilized
by adding 200l μL of solubilization solution (0.05 N
HCl in isopropanol). Metabolic activity was quantiﬁed by
subtracting light absorbance at 630nm from absorbance at
570nm.
2.5. Real-Time PCR Analysis. Total RNA was isolated with
Tri-Reagent/Trizol (Invitrogen, Ltd, UK). Single-stranded
cDNA was synthesized from 4μg total RNA using an
Oligo(dT)12–18 as primer and PowerScript reverse transcrip-
tase (Clontech Laboratories, Inc., Calif, USA). Real-time
PCR was performed with the Fast Start DNA Master SYBR
Green I Kit (Roche) and Light Cycler system (Roche). For
the Light Cycler reaction, a master mix of the following
reaction components was prepared to the indicated ﬁnal
concentration: 12.6l μLH 2O, 2.4 l μLM g C l 2 (4mM), 1l
μL forward primer (0.5μM), 1l μL reverse primer (0.5μM),
and 2.0l μL of the Fast Start DNA Master SYBR Green I
mix (Roche). The primer sequences used in this study are
given in Table 2 and optimized at an annealing temperature
of 55◦C. The cDNA of the genes studied in the diﬀerent
samples (treated in vivo and in vitro) were diluted 1 :
100 and ampliﬁed to obtain the Cp value for each sample.
Light Cycler products of the diﬀerent gene expressions
were analyzed by agarose gel electrophoresis and a Light
Cycler melting curve was constructed to test for a single
product at the end of each PCR reaction. A mathematical
model developed by Pfaﬄ [20] was used for the relative
quantiﬁcation of bcl-2, bcl-xL, c-myc, and p53 mRNA
expression in real-time PCR with respect to the reference
β-actin gene transcript. The eﬃciency of the assay for each
studied gene was β-actin: 1.86; bcl-2: 1.89; bcl-x: 1.9; c-myc:
1.91; p53: 1.81.
2.6. Immunoblotting. Cell monolayer (1 × 107 cells) was
disruptedbyincubationwithRIPAbuﬀer(1×PBS,1%Non-
idet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 0.1mg/mL
PMSF, 2μg/mL aprotinin, 0.18mg/mL sodium orthovana-
date). Protein concentration was determined by using the
micro-BCA procedure (Bio-Rad Laboratories, Inc., Calif,
USA). Proteins were denatured in 1 × sample buﬀer with
5% 2-mercaptoethanol at 95◦ for 10 minutes. Bcl-2, Bcl-XL,
andBaxproteinexpressionwasdetectedbyimmunoblotting.
Total cell lysate was separated under reducing conditions by
12% SDS-polyacrylamide gel electrophoresis (Mini Protean
II, Bio-Rad). Gel-resolved proteins were then transferred
onto a polyvinylidene diﬂuoride membrane (PVDF) using a
Mini Trans-Blot Cell apparatus (Bio-Rad). Membranes were
blocked for 1 hour at room temperature in blocking reagent
(5% milk power, 0,05% Tween-20 in TBS or PBS, pH 7.4)
and probed at 4◦C overnight with the primary antibody:
anti-Bcl-XL (Cell signaling Technology, Inc., Mass, USA)
1 : 1000, anti-Bax 1 : 100 (Santa Cruz Biotechnology,
Inc., Santa Cruz, Calif, USA), and anti-Bcl-2 1 : 500
(BD Biosciences, Calis, USA). Primary antibodies were
detected using a horseradish peroxidase- (HRP-) conjugated
secondary antibody. The immunocomplex was detected with
the ECL-Plus kit (Amersham, Buckinghamshire, UK), and
the band density was analyzed using QuantiScan software
(Biosoft, Cambridge, UK).
2.7. Statistical Analysis. Results are expressed as mean ±
SEM. Data were analyzed by Student’s t-test when the
variability was the same in each group, because the t-test
assumes that standard deviations of two datasets are equal. A
diﬀerence between groups was considered signiﬁcant when
the P-value was ≤.05.
3. Results
3.1. 25-Hydroxycholesterol Treatment and Cytotoxicity Assay
in the In Vivo/In Vitro Cell Culture Model. To evaluate
the cytotoxicity of 25-hidroxycholesterol on SMC-C, SMC-
Ch, and SMC-Ch-FO cultures, cells in third passage were
incubated for 24 hours in 25-hidroxycholesterol at con-
centrations of 0, 5, 10, 20, 40, and 80μg/mL, were used.
The 25-hidroxycholesterol was previously dissolved in the
ethanol and was diluted in cultures in order to obtain the
concentrations of previous experiments. The concentration
of ethanol in cultures never exceeded 0.8%, wich previously
veriﬁed that it was not toxic for the cells. As Figure 1
shows, the citotoxicity of 25-hidroxycholesterol during 24
hours is the same in the three types of cultures. Even then,
a slightly greater viability was observed in the SMC-Ch-
FO cultures with respect to the control. With a concentra-
tion of 20μg/mL, the cellular viability is approximately of
50%.
3.2. Bax, Bcl-2, and Bcl-XL Protein Levels in the In Vivo/In
Vitro Cell Culture Model. Expression of proteins of the
Bcl-2 family of oncogenes (bax, bcl-xL, and bcl-2) was
studied (Figure 2). Because of the homodimerization and
heterodimerization capacity of Bax, Bcl-XL, and Bcl-2,
the relationship between expression levels of Bcl-2/Bax
and Bcl-XL/Bax determines whether the cells will undergo4 Journal of Biomedicine and Biotechnology
Table 2: Primer sequences and PCR product lengths for β-actin, bcl-2, and bcl-xl.
Gen forward primer Reverse primer length
β-actin GCTCCGGCAATGTGCAA AGGTTCATGAGGTAGT 515
bcl-2 TACCTGCTTACACTTAGGAA ATGACTATGATGCGATGGCA 307
bcl-xl GGAGGAAGAGGATGAGAA ATCTCCTTGTCCACG 383
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Figure 1: Toxicity of 25-hydroxycholesterol to SMC as measured
by MTT assay. SMCs were treated with 25-hydroxycholesterol for
24 hours. Lowest values indicate highest toxicity. Results represent
mean values ± SEM (n = 3). (∗P ≤ .05, ∗∗P ≤ .01, ∗∗∗P ≤ .001).
apoptosis or not after an apoptotic stimulus. Table 3 shows
the antiapoptotic/proapoptotic ratios at baseline (after in
vivo treatments) and after 25-hydroxycholesterol in vitro
treatment.Atbaseline,expressionofBcl-2andBax(Figure 2)
was similar among the three culture types, but expression
of Bcl-XL was higher in SMC-Ch and SMC-Ch-FO than in
SMC-C.Hence,theBcl-2/Baxratioswereverysimilaramong
cultures, whereas the Bcl-XL/Bax (Table 3) was signiﬁcantly
higher in SMC-Ch-FO. The SMC-Ch-FO (Table 3) showed
a highly signiﬁcant increase in the Bcl-XL/Bax ratio but a
similar Bcl-2/Bax ratio to that of the control cells, indicating
some resistance to apoptosis. Therefore, the replacement of a
cholesterol-richdietwithadishoil-richdietnotonlyreverses
the eﬀects of cholesterol but also protects the SMCs from
apoptotic stimuli.
3.3. Eﬀect of 25-Hydroxycholesterol on Bax, Bcl-2, and Bcl-
XL Protein Levels. The addition of 25-hydroxycholesterol
produced a highly signiﬁcant increase in Bax levels in all
threeculturetypes(Figure 2)butnochangeinBcl-XL,ex cept
for a nonsigniﬁcant increase in the SMC-C. Hence, there
was a major reduction in the Bcl-2/Bax ratio. Moreover, a
large reduction in the Bcl-XL/Bax ratio was observed for the
SMC-C and an intermediate reduction for the SMC-Ch-FO
(Table 3).
Table 3: Bcl-2/Bax and Bcl-xl/Bax expression ratios in SMC cul-
tures:Bcl-2/BaxandBcl-xl/BaxexpressionratiosinSMCculturesat
baseline (SMC-C, SMC-Ch, and SMC-Ch-FO) and Bcl-2/Bax and
Bcl-xl/BaxExpressionratiosforSMCculturestreatedwith20μg/ml
25-hydroxycholesterol for 24 hours. Ratios were calculated by using
O.D protein and reading and normalized against a control (SMC-
C) for each protein. Each datum indicated mean ± SEM of three
independent experiments. ∗P<.05, ∗∗P<.01, ∗∗∗P<.001 versus
SMC-C.
Bcl-XL/Bax Bcl-2/Bax
SMC-C 11
SMC-Ch 1.3∗ 0.97
SMC-Ch-FO 1.7∗∗ 1.13
25-Hydroxycholesterol
20μg/ml
Bcl-XL/Bax Bcl-2/Bax
SMC-C 0.77 0.56∗∗∗
SMC-Ch 0.99 0.61∗∗
SMC-Ch-FO 0.82∗∗ 0.61∗∗
3.4. Expression of bcl-2 and bcl-XL Genes in the In Vivo/In
V i t r oC e l lC u l t u r eM o d e l . We also studied the expression of
genes that encode proteins implicated in apoptosis (bcl-2,
bcl-xL). At baseline (after in vivo experiments), the amount
of mRNA of bcl-2 gene remained unchanged in the SMC-C
and SMC-Ch (Figure 3). However, the SMC-Ch-FO showed
a slight increasein bcl-2 (P<. 05). No major diﬀerences were
observed in baseline expression of the bcl-xL gene (Figure 4)
in the SMC-C, SMC-Ch, and SMC-Ch-FO cells, as also
found for bcl-2 and protein levels.
3.5. Eﬀect of 25-Hydroxycholesterol on the Expression of bcl-
2a n db c l - xL Genes. Incubation of the cultures with 25-
hydroxycholesterol increased the mRNA of bcl-2 (P<. 001)
to a greater degree in SMC-Ch than in SMC-C (P<. 05),
see Figure 3. Moreover, the expression of bcl-xL markedly
increased in the three culture types after the addition of 25-
hydroxycholesterol (P<. 001), see Figure 4.
4. Discussion
Hyperlipemia and similar conditions, in particular, high
cholesterol, change the expression of genes in endothelial
cells and SMCs, inducing atherosclerotic lesions in which
proliferation and apoptosis are both present [1, 8, 21]. The
dediﬀerentiation and proliferation/apoptosis of SMCs in the
arterial intima represent one of the changes found in early
atherosclerotic lesions, when the disease is still reversible
[2, 3]. In light of this, it is predictable that SMC cultureJournal of Biomedicine and Biotechnology 5
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Figure 2: Representative Western blots showing expression levels
of Bax, Bcl-xl, and Bcl-2 on SMC cultures at baseline (SMC-C,
SMC-Ch,andSMC-Ch-FO)andchangesinproteinexpressionafter
treatment of SMC cultures with 20μg/mL 25-hydroxycholesterol
for 24 hours. Equal amounts of proteins were separated by
electrophoresis and processed for immunoblotting. Similar results
were obtained in three separate experiments. The ratios were
calculated by using O.D protein band reading and normalized
against a control (SMC-C) for each protein.
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Figure 3: bcl-2 mRNA quantiﬁcation in SMC cultures (SMC-C,
SMC-Ch, SMC-Ch-FO) and SMC cultures treated with 20μg/mL
25-hydroxycholesterol for 24 hours. mRNA levels were quantiﬁed
by real-time semiquantitative reverse-transcription PCR. Results
are shown as relative expression ratio of bcl-2 in SMC cultures
with respect to control culture and expressed in comparison to
reference gene β-actin. Bars represent the means ± SEM for 3
diﬀerent experiments. ∗P<. 05, ∗∗P<. 01, ∗∗∗P<. 001 versus
SMC-C, +P<. 05, ++P<. 01, +++P<. 001 versus SMC-C treated
with 20μg/mL 25-hydroxycholesterol.
models from animals fed with ﬁsh oil diet could produce
some reversal of the changes induced by cholesterol in
apoptotic proteins Bcl-2, Bcl-XL, and Bax and the expression
of bcl-2 and bcl-xL genes [22, 23]. The SMC culture model
generatedinourlaboratorybyisolatingthecellsfromcontrol
and cholesterol-fed chicks [17] produces changes in SMCs
that make them more susceptible to 25-hydroxycholesterol-
mediated apoptosis. Replacement of a cholesterol-rich diet
with a ﬁsh oil-rich diet produces some reversal of the
0
0.5
1
1.5
2
2.5
R
e
l
a
t
i
v
e
e
x
p
r
e
s
s
i
o
n
r
a
t
i
o
25-hydroxycholesterol
(20μg/ml)
S
M
C
-
C
S
M
C
-
C
h
S
M
C
-
C
h
-
F
O
S
M
C
-
C
S
M
C
-
C
h
S
M
C
-
C
h
-
F
O
∗∗∗
∗∗∗
∗∗∗
Figure 4: bcl-xl mRNA quantiﬁcation in SMC cultures (SMC-C,
SMC-Ch, SMC-Ch-FO) and SMC cultures treated with 20μg/mL
25-hydroxycholesterol for 24 hours. mRNA levels were quantiﬁed
by real-time semiquantitative reverse-transcription PCR. Results
are shown as relative expression ratio of bcl-2xl in SMC cultures
with respect to control culture and expressed in comparison to
reference gene β-actin. Bars represent the means ± SEM for 3
diﬀerent experiments. ∗P<. 05, ∗∗P<. 01, ∗∗∗P<. 001 versus
SMC-C, +P<. 05, ++P<. 01, +++P<. 001 versus SMC-C treated
with 20μg/mL 25-hydroxycholesterol.
cholesterol-induced changes, increasing the resistance of
SMCs to apoptosis. The very low level of apoptosis showed
in SMCs is similar to the 4% death rate usually observed
in cultured cells. These data are in agreement with previous
reports that cultured SMC from the arterial media, even
those from an atherosclerotic plaque, showing no apoptosis
in culture, unlike observations in SMC from the intima [4].
Inearlyatherosclerosis,thecellsinthearterialmediathatwill
proliferate and migrate, modulating their phenotype, are in
some way protected against apoptosis [24].
In our experimental cell model, Bcl-2 expression was
very low in SMCs from chicks after a 20-day calorie-rich
diet, whereas Bax expression showed virtually no change.
These results are consistent with previous reports that Bcl-
2 is undetectable in most SMCs from atherosclerotic plaque
or healthy arteries [25, 26], explaining its poorly deﬁned
role, and that the expression of Bax does not diﬀer between
SMCs with synthetic and contractile phenotypes. However,
other studies suggested that Bcl-2 is expressed in SMCs
with contractile phenotype but not in those with synthetic
phenotype. It has, therefore, been postulated that Bcl-2 may
be repressed throughout the modulation from contractile to
synthetic phenotype [27]. This modulation in SMCs of the
arterial intima is observed in early atherosclerotic lesions,
when the disease is still reversible. Cells in fatty streaks have
lipid deposits in small vacuoles in the cytoplasm [27–29].
They subsequently become so-called foam cells [30, 31], and
both cell types show a high expression of Bax. Therefore,
although the increase in Bax expression in our cells did not
reach signiﬁcance, it suggests that the lesion may still be in
an early and reversible state, as are initial adaptive streaks in
which Bax is not detectable [30]. In contrast, the Bcl-XL/Bax
ratio increased in the SMC-Ch. The expression of Bcl-XL has6 Journal of Biomedicine and Biotechnology
been reported in SMCs from atherosclerotic plaques, and
is believed to play the main role in preventing apoptosis in
atherosclerosis [32]. Hence, it is thought to act largely in
initial stages of atherosclerosis, in which proliferation must
predominate. In fact, an increase in Bcl-XL was observed in
SMC from the intima in early atherosclerotic lesions [33].
Other members of the Bcl-2 family, for example, Bak, are
abundantly expressed in SMCs from atherosclerotic plaques
and tend to heterodimerize with Bcl-XL [33].
Oxysterols, especially 25-hydroxycholesterol, can reduce
the expression of bcl-2 y bcl-xL [34–36], activate Bad, and
increase the expression of genes that encode BH3-only
proapoptotics, for example, Bim, which in turn activates
Bax/Bak. These actions appear to be mediated by the inhi-
bition of AKT survival kinases [37]. Beside the protein levels,
we also studied the expression of genes of bcl-2 family that
encode proteins implicated in apoptosis (bcl-2, bcl-xL), the
amount of mRNA of bcl-2 gene (prototype of antiapoptotic
genes) remained unchanged in the SMC-C and SMC-Ch,
consistent with previous ﬁndings of no modiﬁcations in the
expression of bcl-2 during atherosclerotic alterations [9, 25,
26]. However, the SMC-Ch-FO showed a slight increase in
bcl-2, which may imply some resistance to apoptotic stimuli.
In fact, many genes involved in the response to oxidative
stress,forexample,NF-κBsurvivalfactorgenes,areactivated
by a ﬁsh oil-rich diet and are also involved in the regulation
of bcl-2 [38–40]. No major diﬀerences observed in baseline
expression of the bcl-xL gene in the SMC-C, SMC-Ch and
SMC-Ch-FO cells, as also found for bcl-2 and protein levels.
The bcl-xL gene is thought to play a critical role in the
prevention of cell death in atherosclerotic plaques, and a
reduction in bcl-xL expression levels may be a prerequisite
for apoptotic induction [9]. It has also been reported that
the inhibition of NF-κB (activator of cell survival genes
reduces the expression of bcl-xL, which makes the cells more
susceptible to apoptosis [41]).
The increase in the mRNA of bcl-2 to a greater degree
in SMC-Ch than in SMC-C may appear contradictory, since
Bcl-2 protein levels are known to be reduced by oxysterol
treatment of the cells [36]. However, this reduction is largely
produced by dimerization of this protein with Bax, which
increases in the presence of oxysterols, as demonstrated
by the results of our protein studies. The marked increase
of the expression of bcl-xL in the three culture types
after the addition of 25-hydroxycholesterol again appears
contradictory because Bcl-XL protein levels are reduced,
which may be explained by the dimerization of Bcl-XL with
Bax and especially with Bak [36].
Theaorticarchesofmalechickwerechosenforthisstudy
for two reasons: ﬁrst, for the ability of chicks to absorb high
amount of dietary cholesterol [14, 42]; and second, because
intimal thickening in the aortas from these hypercholes-
terolemic chicks can be detected after only 20days [43, 44].
This short diet period is very convenient and contrasts with
thosereportedforotherexperimentalanimalmodels,mainly
non-human primates [45] and rabbits [46], which must be
a cholesterol-containing diet for between 1 and 18 months
to obtain an atherosclerotic lesion. The short time of the
chicken model is comparable with that necessary to induce
mitotic activity in aortas of white carneau pigeons or swine
[47].Serumcholesterollevelsobservedin10-day-oldcontrol
chicks are normal because newly hatchet chicken reabsorb
the yolk during the ﬁrst week of live [48], thus developing
hypercholesterolemia, which becomes almost three times
higher in cholesterol-fed chicks. The signiﬁcantly elevated
cholesterol and triglyceride plasma levels are in accordance
with previously reported plasma lipids levels [42].
Avian models were used in trials of atherosclerosis, and,
in fact, cholesterol feeding has been described elsewhere as
producing atherosclerotic lesions in fowl species [16]. We
have also used chicks previously to study lipids metabolism
after cholesterol administration [49] and to develop a cell-
culture avian model to look into, in vitro, the eﬀect of a
cholesterol diet, in vivo, on the transformation of SMC [17].
Thus, in our laboratory, we isolated SMCs from cholesterol-
fed chicks (SMC-Ch cultures) which are very proliferative
in culture compared with SMC isolated from control-fed
chicks (SMC-C cultures), and with identical maintenance
in culture of the two lines of SMC [17]. In this way, DNA
synthesis in the S phase was 4-fold higher and after 20
days of culture, SMC-Ch increased their cholesterol content
to double that of SMC-C, giving SMC-Ch cultures under
conditions mimicking such a cholesterol diet and a very early
atherosclerosis in vivo/in vitro model at the SMC level [17].
We have studied the cholesterol synthesis and HMG-CoA
reductase gene expression in these cultures, showing great
diﬀerences between SMC-C and SMC-Ch [50, 51]. Also we
demonstrated the existence of cyclic ﬂuctuations of HMG-
CoAreductaseactivityinnonsynchronizedSMCculturesnot
correlatedtotheculturedfeedingandnotwiththeincreaseof
mRNA,suggestingtheposttranscriptionalmodulationofthe
HMG-CoA reductase and the relationships between HMG-
CoAreductaseactivityandcelldivision[52].Finally,wehave
examined the morphological, molecular, and proliferation
change in arterial SMC mimicking such a cholesterol diet.
Consequentially, this transformed SMC is a good model
to study the alterations of the diﬀerentiated state of SMC,
caused not only by cholesterol-rich diet but also by ﬁsh
oil-rich diet as well as the apoptotic pathway induced by
oxysteroid in SMCs.
5. Conclusion
In conclusion, we investigated the apoptotic pathway
induced by oxysteroid in SMCs isolated from male chicks
exposed to a control diet (SMC-C) and an athero-
genic cholesterol-rich diet (SMC-Ch) or an antiathero-
genic ﬁsh oil-rich diet (SMC-Ch-FO). We found that 25-
hydroxycholesterol-induced apoptosis in SMCs, mediated by
ahighincreaseinBaxproteinandbaxgeneexpression.These
changes were more evident in SMC isolated from chicks
exposed to an atherogenic than to an antiatherogenic one.
Thus, we deducted that the replacement of a cholesterol-rich
diet with a ﬁsh-oil rich diet might produce some reversal
of cholesterol-induced changes in oxysterol-activated apop-
totic pathway, making SMC more resistant to apoptosis.
Moreover, high cholesterol diet and ﬁsh-oil rich diet inJournal of Biomedicine and Biotechnology 7
the animals, before obtaining the SMCs cultures, induced
changes in the apoptotic gene expression studied. Thus,
the mRNA concentration was downregulated in SMC-Ch-
FO versus SMC-Ch. Since we reported previously that, the
nutritional culture conditions, the intracellular cholesterol
concentration, and the ultrastructural morphology were the
same during the ﬁrst days of cultures; the change in gene
expression must have been induced by the cholesterol or ﬁsh
oil diet in the aortic SMC in vivo. In this way, this in vivo/in
vitro model is relevant to study the nutritional control
and gene regulation of the diﬀerentiation and apoptosis in
SMC. New studies would be necessary to demonstrate the
implication of the cell signalling pathways, as well as to show
if new protein synthesis is required for the Bax increase
or if some peaks of gene expression correlate with other
regulatory events.
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